Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanobiotix S.A. ADR
(NQ:
NBTX
)
5.070
-0.010 (-0.19%)
Streaming Delayed Price
Updated: 1:09 PM EDT, Sep 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,195
Open
5.190
Bid (Size)
4.500 (10)
Ask (Size)
7.620 (2)
Prev. Close
5.080
Today's Range
5.070 - 5.200
52wk Range
4.140 - 9.980
Shares Outstanding
34,432,122
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
September 04, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Performance
YTD
-30.97%
-30.97%
1 Month
+5.41%
+5.41%
3 Month
-4.70%
-4.70%
6 Month
-20.16%
-20.16%
1 Year
-46.71%
-46.71%
More News
Read More
Voting Rights and Shares Capital of the Company
August 08, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
July 09, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
June 12, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
June 11, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
June 02, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
May 28, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
May 23, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 22, 2024
Via
Benzinga
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
May 22, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
May 21, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Voting Rights and Shares Capital of the Company
May 16, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
May 15, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
May 14, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
April 24, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
April 17, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Voting Rights and Shares Capital of the Company
April 10, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
April 02, 2024
From
Nanobiotix S.A.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
March 18, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 18, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 18, 2024
Via
InvestorPlace
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.